Lyu Hang, Tang Haotong, Liang Yizhi, Huang Shaoli, Wang Yuyu, Huang Wenyan, Zhou Yi
Department of HIV Prevention, Zhuhai Center for Disease Control and Prevention, Zhuhai, China.
Faculty of Medicine, Macau University of Science and Technology, Macao, Macao SAR, China.
Front Immunol. 2022 Mar 18;13:841314. doi: 10.3389/fimmu.2022.841314. eCollection 2022.
It is unclear if a high level of alcohol consumption is a risk factor for liver fibrosis for people living with HIV (PLWH). This study systematically summarizes the risk relationship between different alcohol consumption and the incidence of liver fibrosis among PLWH.
We identified potential studies by searching the PubMed, Embase, Web of Science Library, and CNKI databases up to September 26th, 2021. Observation studies in PLWH that evaluated the relationship between alcohol consumption and the risk of liver fibrosis and estimated the effect of alcohol with pooled odds ratios (pooled ORs) and 95% confidence intervals (CIs) were included.
There were total 15 studies included in data analysis. Three studies were set up as cohort studies and the other twelve were cross-sectional studies. Our study was based on 22,676 individuals and 2,729 liver fibrosis cases from 15 studies. Alcohol abuse is a significant risk factor of liver fibrosis (pooled OR = 2.25, 95% CI: 1.59-3.17, p < 0.05) among PLWH. Daily alcohol consumption > 50 g can elevate the risk of liver fibrosis (pooled OR = 3.10, 95% CI: 2.02-4.73, p < 0.05) among PLWH. However, high-risk alcohol consumption determined by AUDIT-C (AUDIT-C ≥ 4) had little or no effect on subsequent liver fibrosis risk. Further, alcohol consumption > 50 g is also a risk factor to liver fibrosis in PLWH co-infected with HCV (pooled OR = 2.48, 95% CI: 1.62-3.80, p < 0.05) and in HIV mono-infected (pooled OR = 1.85, 95% CI: 1.00-3.43, p < 0.05).
Alcohol consumption is associated with an increased risk of liver fibrosis in PLWH. HCV co-infection with alcohol abuse could possibly induce a higher risk of liver fibrosis than HIV mono-infected patients.
PROSPERO, identifier (CRD42021272604).
对于感染艾滋病毒(PLWH)的人而言,高酒精摄入量是否为肝纤维化的风险因素尚不清楚。本研究系统总结了不同酒精摄入量与PLWH肝纤维化发生率之间的风险关系。
通过检索截至2021年9月26日的PubMed、Embase、Web of Science数据库和中国知网,确定潜在研究。纳入评估酒精摄入量与肝纤维化风险之间关系,并通过合并比值比(合并OR)和95%置信区间(CI)估计酒精影响的PLWH观察性研究。
数据分析共纳入15项研究。3项研究为队列研究,另外12项为横断面研究。我们的研究基于15项研究中的22,676名个体和2,729例肝纤维化病例。酒精滥用是PLWH肝纤维化的显著风险因素(合并OR = 2.25,95% CI:1.59 - 3.17,p < 0.05)。每日酒精摄入量> 50克会增加PLWH肝纤维化风险(合并OR = 3.10,95% CI:2.02 - 4.73,p < 0.05)。然而,通过AUDIT - C确定的高风险酒精消费(AUDIT - C≥4)对随后的肝纤维化风险几乎没有影响。此外,酒精摄入量> 50克也是丙型肝炎病毒(HCV)合并感染的PLWH(合并OR = 2.48,95% CI:1.62 - 3.80,p < 0.05)和艾滋病毒单一感染的PLWH(合并OR = 1.85,95% CI:1.00 - 3.43,p < 0.05)肝纤维化的风险因素。
酒精消费与PLWH肝纤维化风险增加有关。HCV合并感染与酒精滥用可能比艾滋病毒单一感染患者诱发更高的肝纤维化风险。
PROSPERO标识符(CRD42021272604)